abstract |
The present invention provides novel ligands of formula (I) for the G-protein-coupled orphan receptor APJ, and uses thereof for treating and/or preventing diseases, conditions and/or disorders mediated by APJ receptors. The invention further relates to assays for the identification of agents able to modulate APJ ligand binding, signalling and biological activities. |